Griffith Harsh
PROFESSOR
NEUROSURGERY
Canary Center at Stanford
United States of America
Biography
He is a Professor - Med Center Line of Neurosurgery ,Otolaryngology - Head & Neck Surgery Divisions and member of Bio-X, Stanford Cancer Institute.He is a Director of Stanford Surgical Neuro-oncology (1998 - Present),Surgical Director at Stanford Pituitary Center (2004 - Present),Program Director at Stanford Neurosurgery Resident Training Program (2004 - Present),Director of Stanford Brain Tumor Center (2010 - Present).He got Outstanding Teacher Award, MGH Neurosurgery (1994)
Research Interest
Microsurgical treatment of tumors of the brain, spinal cord, pituitary gland and skull base; Radiosurgery of tumors;Molecular biology of brain tumors.
Publications
-
Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science translational medicine. 2017 Mar 15;9(381):eaaf2968.
-
Graim K, Liu TT, Achrol AS, Paull EO, Newton Y, Chang SD, Harsh GR, Cordero SP, Rubin DL, Stuart JM. Revealing cancer subtypes with higher-order correlations applied to imaging and omics data. BMC medical genomics. 2017 Mar 31;10(1):20.
-
Pollom EL, Fujimoto D, Wynne J, Seiger K, Modlin LA, Jacobs LR, Azoulay M, von Eyben R, Tupper L, Gibbs IC, Hancock SL. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results. International Journal of Radiation Oncology* Biology* Physics. 2017 May 1;98(1):123-30.
